T-WIN Trademark

Trademark Overview


On Tuesday, March 13, 2018, a trademark application was filed for T-WIN with the United States Patent and Trademark Office. The USPTO has given the T-WIN trademark a serial number of 87832891. The federal status of this trademark filing is PARTIAL SECTION 8 & 15 ACCEPTED AND ACKNOWLEDGED as of Monday, March 9, 2026. This trademark is owned by IO Biotech ApS. The T-WIN trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Scientific research for medical purposes in the field of [ viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, ] oncological, [ hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system] related diseases; pharmaceutical drug research and development services; medical research services; pharmacological research services in the nature of pharmaceutical research; research and development in the pharmaceutical and biotechnology fields; providing medical and scientific research information in the fields of pharmaceutical and clinical trials; conducting clinical trials for others; information, advisory and consultancy services relating to the aforesaid

[ Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases; pharmaceutical drugs and pharmaceutical substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases; synthetic peptides for pharmaceutical use for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related disea...
t-win

General Information


Serial Number87832891
Word MarkT-WIN
Filing DateTuesday, March 13, 2018
Status705 - PARTIAL SECTION 8 & 15 ACCEPTED AND ACKNOWLEDGED
Status DateMonday, March 9, 2026
Registration Number5754675
Registration DateTuesday, May 21, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 5, 2019

Trademark Statements


Goods and ServicesScientific research for medical purposes in the field of [ viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, ] oncological, [ hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system] related diseases; pharmaceutical drug research and development services; medical research services; pharmacological research services in the nature of pharmaceutical research; research and development in the pharmaceutical and biotechnology fields; providing medical and scientific research information in the fields of pharmaceutical and clinical trials; conducting clinical trials for others; information, advisory and consultancy services relating to the aforesaid
Goods and Services[ Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases; pharmaceutical drugs and pharmaceutical substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases; synthetic peptides for pharmaceutical use for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases; vaccines ]

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeB - Sec. 8 - Class(es) in a Multiple Class registration
Class Status DateMonday, March 9, 2026
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, March 20, 2018
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameIO Biotech ApS
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCopenhagen N 2200
DK

Party NameIO Biotech ApS
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCopenhagen N 2200
DK

Party NameIO Biotech ApS
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCopenhagen N 2200
DK

Trademark Events


Event DateEvent Description
Friday, March 16, 2018NEW APPLICATION ENTERED
Tuesday, March 20, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, June 23, 2018ASSIGNED TO EXAMINER
Saturday, June 23, 2018NON-FINAL ACTION WRITTEN
Saturday, June 23, 2018NON-FINAL ACTION E-MAILED
Saturday, June 23, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, November 30, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, December 6, 2018ASSIGNED TO LIE
Monday, December 10, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, December 10, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, January 19, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, January 25, 2019ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Tuesday, January 29, 2019ELECTRONIC RECORD REVIEW COMPLETE
Wednesday, February 13, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 5, 2019PUBLISHED FOR OPPOSITION
Tuesday, March 5, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 21, 2019REGISTERED-PRINCIPAL REGISTER
Tuesday, May 21, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, November 21, 2025TEAS SECTION 8 & 15 RECEIVED
Friday, February 27, 2026CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, February 27, 2026POST REGISTRATION ACTION MAILED - SEC. 8 & 15
Monday, March 9, 2026POST REGISTRATION ACTION MAILED - SEC. 8 & 15
Monday, March 9, 2026REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Monday, March 9, 2026NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Tuesday, March 10, 2026POST REGISTRATION ACTION MAILED NO RESPONSE REQUIRED